SUBSCRIBE
SUBSCRIBE

Ipsen Biopharmaceuticals, Inc.

NEWS
Job Trends
Allergan Rival Ipsen to Continue U.S. Hiring Spree
March 13, 2015
 · 
3 min read
Biotech Beach
The Day In Review: Tercica, Inc. And Ipsen Sign Cross-License Deal
July 19, 2006
 · 
1 min read
Business
Ipsen Joins Pfizer In Breast Cancer Trials
October 19, 2005
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
December 22, 2025
 · 
7 min read
Press Releases
Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP)
December 19, 2025
 · 
7 min read
Press Releases
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
December 16, 2025
 · 
4 min read
Press Releases
Ipsen provides update on legacy of Henri Beaufour
December 5, 2025
 · 
5 min read
Press Releases
Ipsen mourns the passing of Henri Beaufour, a founding family Board member
December 1, 2025
 · 
6 min read
Press Releases
Ipsen to present two late-breaking sessions at AASLD on new PBC data supporting IQIRVO®’s long-term efficacy, safety and mechanistic insights in fatigue
November 10, 2025
 · 
11 min read
Press Releases
Ipsen delivers strong sales in the first nine months of 2025 and further upgrades its full-year guidance
October 22, 2025
 · 
9 min read
Press Releases
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
October 22, 2025
 · 
11 min read
Press Releases
Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III
September 22, 2025
 · 
9 min read
Press Releases
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
September 22, 2025
 · 
11 min read
Load More